Pluri Inc. — Director's Dealing 2019

Apr 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2019-04-08

Reporting Person: YANAY YAKY (Director, Co-CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-08	Common Stock	P	71429	$0.7	Acquired	4253045	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-08	Common Stock Warrant	$0.70	P	71429	Acquired	2024-04-08	Common Stock (71429)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	66499	Indirect

Footnotes

F1: The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of common
stock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I.

F2: The common stock warrants were exercisable immediately upon their issuance.